[Biological effects of endostatin on vascular endothelial cell and fibroblast]

P Zhang1, J Yin, Y Liu

  • 1Department of Cardiothoracic Surgery , The General Hospital , Tianjin Medical University , Tianjin 300052, P . R. China.

Abstract

Insights

Recombinant human endostatin specifically inhibits endothelial cell proliferation and induces apoptosis. This targeted effect on vascular endothelial cells (ECV304) suggests potential therapeutic applications, unlike its impact on fibroblasts (WI-38).

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Context:

  • Endostatin is a potent anti-angiogenic factor.
  • Understanding its cellular effects is crucial for therapeutic development.
  • Investigating endostatin's impact on endothelial cells and fibroblasts provides insights into its specificity.

Purpose:

  • To evaluate the proliferation-inhibiting and apoptosis-inducing effects of recombinant human endostatin.
  • To determine the efficacy and specificity of endostatin's anti-proliferative action.
  • To explore the underlying mechanisms of endostatin's effects on ECV304 and WI-38 cells.

Summary:

  • Recombinant human endostatin significantly inhibited human umbilical vein endothelial cell (ECV304) proliferation in a dose-dependent manner (ED₅₀: 15-20μg/ml).
  • Endostatin strongly induced apoptosis in ECV304 cells, with an enrichment factor of 2.44.
  • No significant inhibitory or apoptotic effects were observed in human fibroblast (WI-38) cells, indicating specificity.

Impact:

  • Recombinant human endostatin demonstrates specific anti-proliferative activity against vascular endothelial cells.
  • Apoptosis induction is a key mechanism underlying endostatin's anti-proliferative effects.
  • These findings support endostatin's potential as a targeted therapeutic agent in angiogenesis-related diseases.